Clinical Trials Logo

Clinical Trial Summary

Early Phase I Study of the Safety and Preliminary Efficacy of Human primary Retinal Pigment Epithelial (HuRPE) Cells Subretinal Transplantation in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) Patients


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03566147
Study type Interventional
Source Eyecure Therapeutics Inc.
Contact Jingxue Zhang, Dr
Phone 86-18610772626
Email jingxuezh@163.com
Status Recruiting
Phase Early Phase 1
Start date August 1, 2018
Completion date March 31, 2020